Kaitlyn Bader, Editor

Monica K. Li, MD, shares what to expect at her co-directed global microneedling techniques session at AAD 2023.

As sessions wrap up each day at AAD, there are numerous must-see places in New Orleans.

Data published in Nucleic Acids Research builds on previous studies investigating the benefits of sarecycline for acne vulgaris compared to other antibiotics.

ICYMI, this week we had stories about inspiring women in dermatology for International Women's Day, a measles outbreak in Kentucky with 200,000 exposed, sarecycline's role in treating acne vulgaris, and more.

Yale School of Medicine is a testing site for a potential new congenital ichthyosis treatment.

Study investigators evaluated the blood-brain barrier penetrance and lipophilicity of the narrow-spectrum, third-generation tetracycline-class oral antibiotic used for acne treatment.

Updates from Incyte’s dermatology portfolio include late-breaking data on ruxolitinib cream and povorcitinib for vitiligo.

Novan’s expected PDUFA date is January 5, 2024.

JNJ-2113 met primary endpoints in the FRONTIER 1 clinical trial.

This week's edition of the Mainstream Patient features stories about understanding scalp psoriasis, biotin shampoos for healthier hair, azelaic acid for acne and rosacea treatment, and more.

ICYMI, this week we had stories about accepted NDAs and sBLAs for VP-102 and nivolumab, overviews of rare dermatologic diseases for National Rare Disease Day, antioxidants for vitiligo and mental health, and more.

This week's edition of the Mainstream Patient features stories about the misunderstanding of gua sha use, how to exfoliate the face correctly according to dermatologists, the best face sunscreens of 2023, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of February.

Learn more about what in-depth topics were covered in the February 2023 issue of Dermatology Times®.

VP-102 could be the first FDA-approved treatment for molluscum contagiosum.

Nivolumab for completely resected stage IIB or IIC melanoma is also validated by the European Medicines Agency.

ICYMI, this week we had stories about hidradenitis suppurativa coverage at Winter Clinical Miami, an NDA submission for roflumilast foam, an overview of the 2023 Biosimilars Report from Cardinal Health, and more.

This week's edition of the Mainstream Patient features stories about treating dry eyelids, face masks for acne-prone skin, acne scar treatments, and more.

Biosimilars have been a trending topic in 2023 with 8 adalimumab biosimilars expected to hit the market this year.

Adolescents and adults with seborrheic dermatitis may have a new topical treatment soon.

It’s crucial for patients and health care providers to consider their personal wellbeing in their daily lives.

This week's edition of the Mainstream Patient features stories about quality skin care products under $20, how to address skin picking, trending mushroom skin care, and more.

Discover all topics and sessions covered at South Beach Symposium.

Linda Stein Gold, MD, and Jennifer Soung, MD, discuss available nonsteroidal treatment options for plaque psoriasis in this DermView series recap.

Aaron Farberg, MD, and Jeffrey Crowley, MD, take a closer look at the management and treatment of generalized pustular psoriasis.

Catch up on coverage from the final day of South Beach Symposium.

A poster presentation from SBS 2023 reviewed the clinician satisfaction of tirbanibulin for the treatment of actinic keratosis.

Doris Day, MD, thoroughly discussed the up-and-coming topic of the gut-skin-brain axis related to healthy skin at SBS 2023.

Lio shares key highlights of his atopic dermatitis sessions at South Beach Symposium.

Alexis shares take-home points from his popular sessions at South Beach Symposium.